[关于心脏衰竭的最新话题]
1Department of Cardiology, Nagoya City University, Graduate School of Medical Sciences.
No shinkei geka. Neurological surgery
|December 2, 2024
概括
日本 日本 日本 日本 日本.
科学领域:
- 心脏病学 心脏病学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 由于日本人口老龄化,日本面临着心力衰竭的流行病.
- 心力衰竭显著影响预期寿命,是严重的公共卫生问题.
- 早期诊断和分阶段治疗对于控制心力衰竭至关重要.
研究的目的:
- 审查心力衰竭治疗的最新进展.
- 为了突出人口老龄化对日本心力衰竭护理的影响.
- 强调多学科护理和持续研究的重要性.
主要方法:
- 最近药理和非药理治疗的文献综述.
- 对日本人口老龄化趋势和心力衰竭发病率的分析.
- 对综合护理模式的讨论.
主要成果:
- 新的治疗方法,如SGLT2抑制剂和跨导管大动脉植入改善了结果.
- 这些进展对老年心力衰竭患者尤其有益.
- 基于多学科的团队护理对于有效的心力衰竭管理至关重要.
结论:
- 创新的治疗方法可以改善心力衰竭患者的治疗结果.
- 将治疗策略适应人口老龄化对于日本的公共卫生至关重要.
- 持续的研究和整体护理方法是必要的,以打击心力衰竭的流行.
相关概念视频
Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Heart Failure Drugs: Diuretics
340
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
340
Heart Failure Drugs: Inotropic Agents
517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Rheumatic Heart Disease III: Medical Management
2
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
2


